Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Liver Pseudolymphoma (Reactive Lymphoid Hyperplasia): Difficulty in Radiological and Pathological Diagnosis

Author(s): Suleyman Bakdik*, Necdet Poyraz, Teyfik Kucukkartallar and Pembe Oltulu

Volume 18, Issue 3, 2022

Published on: 07 January, 2022

Article ID: e040521193144 Pages: 5

DOI: 10.2174/1573405617666210504120142

Price: $65

Abstract

Background: Pseudolymphoma of the liver (Reactive Lymphoid Hyperplasia) (RLH) is a rare condition. It is usually asymptomatic and detected incidentally on radiological imaging. Imaging features are similar to hepatic adenoma, hepatocellular carcinoma, cholangiocarcinoma, and malignant lymphoma and are not specific for pseudolymphoma of the liver. Percutaneous core biopsy is insufficient to distinguish pseudolymphoma of the liver from low-grade malignant lymphoma and extranodal marginal lymphomas.

Case Descriptions: In this article, we present a case of hepatic RLH of a patient who was presented with a skin rash on the leg and was detected incidentally on radiological imaging.

Conclusion: Preoperative definitive diagnosis of hepatic RLH using various imaging methods, including MRI with hepatocellular agents, is highly difficult.

Keywords: Pseudolymphoma, reactive lymphoid hyperplasia, mimicking hepatocellular carcinoma, MRI, benign lesion, germinal center.

Graphical Abstract

[1]
Iwamuro M, Kawai Y, Takata K, et al. Reactive lymphoid hyperplasia with a lipomatous component associated with fecal compaction in an appendiceal orifice. Inter Med 2014; 53: 1049-53.
[http://dx.doi.org/10.2169/internalmedicine.53.1635]
[2]
Bois MC, Sekiguchi H, Ryu JH, et al. No definite clinical features of immunoglobulin G4-related disease in patients with pulmonary nodular lymphoid hyperplasia. Hum Pathol 2017; 59: 80-6.
[http://dx.doi.org/10.1016/j.humpath.2016.09.016]
[3]
Miguel D, Peckruhn M, Elsner P. Treatment of cutaneous pseudolymphoma: A systematic review. Acta Derm Venereol 2018; 98: 310-7.
[http://dx.doi.org/10.2340/00015555-2841]
[4]
Onoda N, Ohsawa M, Kawajiri H, et al. Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: A case report. J Med Case Rep 2014; 8: 247.
[http://dx.doi.org/10.1186 / 1752-1947-8-247]
[5]
Andrew NH, Kearney D, Selva D. Intraorbital corticosteroid injection for orbital reactive lymphoid hyperplasia. Eye (Lond) 2013; 27(4): 561-3.
[http://dx.doi.org/10.1038/eye.2012.288] [PMID: 23348726]
[6]
Taguchi K, Kuroda S, Kobayashi T, et al. Pseudolymphoma of the liver: A case report and literature review. Sur Case Rep 2015; 1: 107.
[http://dx.doi.org/10.1186/s40792-015-0110-9]
[7]
Zhang W, Zheng S. Reactive lymphoid hyperplasia of the liver, A case report. Medicine 2019; 98(30): e16491.
[http://dx.doi.org/10.1097/MD.0000000000016491]
[8]
Snover DC, Filipovich AH, Dehner LP, Krivit W. ‘Pseudolymphoma’. A case associated with primary immunodeficiency disease and polyglandular failure syndrome. Arch Pathol Lab Med 1981; 105(1): 46-9.
[PMID: 6893912]
[9]
Caputo D, Cartillone M, Coppola R. All that glitters are not gold! Reactive lymphoid hyperplasia mimicking colorectal liver metastases: Description of a case and literature review. Updates Surg 2017; 69: 113-5.
[http://dx.doi.org/10.1007/s13304-017-0416-1]
[10]
Higashi T, Hashimoto D, Hayashi H, et al. Reactive lymphoid hyperplasia of the liver requires differential diagnosis of hepatocellular carcinoma. Surg Case Rep 2015; 1: 31.
[http://dx.doi.org/10.1186/s40792-015-0034-4]
[11]
Sato K, Ueda Y, Yokoi M, et al. Reactive lymphoid hyperplasia of the liver in a patient with multiple carcinomas: A case report and brief review. J Clin Pathol 2006; 59: 990-2.
[12]
Kunimoto H, Morihara D, Nakane SI, et al. Hepatic pseudolymphoma with an occult hepatitis B virus infection. Inter Med 2018; 57: 223-30.
[http://dx.doi.org/10.2169/internalmedicine.8981-17]
[13]
Ohtsu T, Sasaki Y, Tanizaki H, et al. Development of pseudolymphoma of liver following interferon-alpha therapy for chronic hepatitis B. Inter Med 1994; 33: 18-22.
[http://dx.doi.org/10,2169/internalmedicine.33.18]
[14]
Tanizawa T, Eishi Y, Kamiyama R, et al. Reactive lymphoid hyperplasia of the liver characterized by an angiofollicular pattern mimicking Castleman's disease. Pathol Int 1996; 46: 782-6.
[http://dx.doi.org/10.1111/j.1440-1827.1996.tb03549.x]
[15]
Song KD, Jeong WK. Benign nodules mimicking hepatocellular carcinoma on gadoxetic acid-enhanced liver. Clin Mol Hepatol 2015; 21: 187-91.
[http://dx.doi.org/10.3350/cmh.2015.21.2.187]
[16]
Zhou Y, Wang X, Xu C, Zhou G, Zeng M, Xu P. Hepatic pseudolymphoma: Imaging features on dynamic contrast-enhanced MRI and diffusion-weighted imaging. Abdom Radiol (NY) 2018; 43(9): 2288-94.
[http://dx.doi.org/10.1007/s00261-018-1468-5]
[17]
Koss MN, Hochholzer L, Nichols PW, et al. Primary non-Hodgkin's lymphoma and pseudolymphoma of lung: A study of 161 patients. Hum Pathol 1983; 14: 1024-38.
[http://dx.doi.org/10.1016/S0046-8177(83)80258-5]
[18]
Kulow BF, Cualing H, Steele P, et al. Progression of cutaneous B- cell pseudolymphoma to cutaneous B-cell lymphoma. J Cutan Med Surg 2002; 6: 519-28.
[http://dx.doi.org/10.1007/s10227-001-0133-7]
[19]
Kwon YK, Jha RC, Etesami K, et al. Pseudolymphoma (reactive lymphoid hyperplasia) of the liver: A clinical challenge. World J Hepatol 2015; 7: 2696-702.
[http://dx.doi.org/10.4254/wjh.v7.i26.2696]
[20]
Lv A, Liu W, Qian HG, Leng JH, Hao CY. Reactive lymphoid hyperplasia of the liver mimicking hepatocellular carcinoma: incidental finding of two cases. Int J Clin Exp Pathol 2015; 8(5): 5863-9.
[PMID: 26191310]

Rights & Permissions Print Cite
Article Metrics
45
1
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy